SightfileU.S. market data from official filings

VIKING THERAPEUTICS INC (VKTX)

Name: VIKING THERAPEUTICS INC (VKTX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001607678 · EDGAR filings · Updated 2026-06-03

VIKING THERAPEUTICS INC (VKTX) has reported institutional ownership of 63.0%, with 409 institutional managers holding positions valued at $2.42B per the latest 13F reporting period.

Institutional ownership

63.0%

Institutional managers

409

Reported 13F value

$2.42B

Insider activity

45 trans.

−$16.8M net selling

Latest updates

2026-06-03 — Insider transaction reported (Form 4)
2026-06-03 — Initial insider ownership filed (Form 3)
2026-05-26 — Current report (8-K) filed
2026-04-30 — SCHEDULE 13G filed
2026-04-30 — Quarterly report (10-Q) filed
2026-04-29 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VIKING THERAPEUTICS INC has 409 institutional holders and institutional ownership of 63.0%.

Insider activity

Insiders reported 45 transactions (3 buys, 20 sells) across 9 reporting insiders, with a net reported value of −$16.8M.

Related companies

DENTSPLY SIRONA INC (XRAY) · MINERALYS THERAPEUTICS INC (MLYS) · ENLIVEN THERAPEUTICS INC (ELVN) · LEMAITRE VASCULAR INC (LMAT) · BIOCRYST PHARMACEUTICALS INC (BCRX) · LIFESTANCE HEALTH GROUP INC (LFST)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.